The acquisition will provide Roche with access to Poseida’s GMP manufacturing capabilities and R&D portfolio assets, ...
Through this acquisition, the German CDMO expands its global network and adds aseptic fill/finish and lyophilization expertise to its sterile manufacturing capabilities.
Elizabeth Hickman (Chief Business Officer, AustinPx) explains the company's approach to improving bioavailability, ...
Traditional formulations commonly struggle to achieve content uniformity with morphologically challenging active pharmaceutical ingredients (APIs), requiring the use of complicated processes such as ...
Direct-to-patient (DTP) clinical supply services provide sponsors and patients with enhanced supply chain flexibility. Traditionally, clinical supplies are shipped to clinical sites where patient kits ...
CDER Director Patrizia Cavazzoni and CBER Director Peter Marks provided an update on the rare disease innovation hub in a new FDA Voices blog post.
The Thousand Oaks, Calif., cell therapy manufacturing facility now houses new production suites, updated development labs, and more after expansion.
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification ...
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification ...
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification ...
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback